Skip to main content

Peer Review reports

From: Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1

Original Submission
8 Mar 2023 Submitted Original manuscript
30 Mar 2023 Reviewed Reviewer Report
13 Apr 2023 Author responded Author comments - Hailing Xiong
2 Nov 2023 Reviewed Reviewer Report - Hailin Tang
3 Dec 2023 Author responded Author comments - Hailing Xiong
Resubmission - Version 2
13 Apr 2023 Submitted Manuscript version 2
Publishing
19 Mar 2024 Editorially accepted
5 Apr 2024 Article published 10.1186/s13019-024-02651-9

You can find further information about peer review here.

Back to article page